Transcription of the rat p53 gene is mediated by factor binding to two recognition motifs of NF1-like protein

Biological Chemistry

Volumn 379, Issue 11, 1998, Pages 1333-1340

  Lee, Minhyung ^a   Song, Haisun ^a   Park, Sunhee ^a   Park, Jong Sang ^a  

^a Seoul National University   (South Korea)

Author keywords

p53 tumor suppressor protein; Promoter analysis; Regulation of transcription; Transcription factor

Indexed keywords

DNA; DNA BINDING PROTEIN; NEUROFIBROMIN; PROTEIN P53;

AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FOOTPRINTING; DNA SEQUENCE; FEMALE; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; LUNG; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PURIFICATION; RAT; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; SPLEEN; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA; RODENTIA;

EID: 0031733143     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1998.379.11.1333     Document Type: Article

References (31)

1. Arndt-Jovin, D.J., Jovin, T.M., Bahr, W., Frischauf, M., and Marguardt, M. (1975). Covalent attachment of DNA to agarose. Improved synthesis and use in affinity chromatography. Eur. J. Biochem. 54, 411-418.
2. Barak, Y., Juven, T., Haffner, R., and Oren, M. (1993). Mdm-2 expression is induced by wild-type p53. EMBO J. 12, 461-468.
3. Benbrook, D.M., and Jones, N.C. (1994). Different binding speci- ficities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res. 22, 1463-1469.
4. Bienz-Tadmor, B., Zakut-Houri, R., Libresco, S., Givol, D., and Oren, M. (1985). The 5′ region of the p53 gene evolutionary conservation and evidence for a negative regulatory element. EMBO J. 4, 3209-3213.
5. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. El-Deiry, W.S., Tokino, T., Volculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K., and Vogelstein, B. (1993). WAF1, a potential mediator p53 tumor suppression. Cell 75, 817-825.
7. Fields, S., and Jang, S.K. (1990). Presence of a potent tran- scription activating sequence in the p53 protein. Science 249, 1046-1047.
8. Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E., and Shay, J.W. (1992). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866-2871.
9. Furlong, E., Rein, T., and Martin, F. (1996). YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol. Cell. Biol. 16, 5933-5945.
10. Ginsberg, D., Oren, M., Yaniv, M., and Piette, J. (1990). Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene 5, 1285-1295.
11. Goga, A., Liu, X., Hambuch, T.M., Senechal, K., Major, E., Berk, A.J., Witte, O.N., and Sawyers, C.L. (1995). p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11,791-799.
12. Hale, T.K., and Braithwaite, A.W. (1995). Identification of an upstream region of the mouse p53 promoter critical for transcriptional expression. Nucleic Acids Res. 23, 663-669.
13. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991). p53 mutations in human cancers. Science 253, 49-53.
14. Kadonaga, J., and Tjian, R. (1986). Affinity purification of sequence-specific DNA binding proteins. Proc. Natl. Acad. Sci. USA 83, 5889-5893.
15. Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymour, A., Kinzler, K.W., and Vogelstein, B. (1992). Oncogenic forms of p53 inhib- it p53-regulated gene expression. Science 256, 827-830.
16. Lamb, P., and Crawford, L.V. (1986). Characterization of the human p53 gene. Mol. Cell. Biol. 6, 1379-1385.
17. Lim, K., and Chae, C.B. (1992). Presence of a repressor protein for testis-specific H2B(TH2B) histone gene in early stages of spermatogenesis. J. Biol. Chem. 267, 15271-15273.
18. Liu, X., Miller, C.W., Koeffler, P.H., and Berk, A.J. (1993). The p53 activation domain binds the TATA box binding polypeptide in holo-TFHD, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13,3291-3300.
19. Mack, D.H., Vartikar, J., Pipas, J.M., and Laimins, L.A. (1993). Specific repression of TATA-mediated transcription by wild-type p53. Nature 363,281-283.
20. Marston, N.J., Crook, T., and Vousden, K.H. (1994). Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function. Oncogene 9, 2707-2716.
21. Meisterernst, M., Gander, I., Rogge, L., and Winnacker, E.-L. (1988). A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res. 16, 4419-4435.
22. Okamoto, K., and Beach, D. (1994). Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13, 4816-4822.
23. Ragimov, N., Krauskopf, A., Novot, N., Rotter, V., Oren, M., and Aloni, Y. (1993). Wild-type but not mutant p53 can repress tran- scription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 8, 1183-1193.
24. Raycroft, L., Wu, H., and Lozano, G. (1990). Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249, 1049-1051.
25. Roy, B., Beamon, J., Balint, E., and Reisman, D. (1994). Transactivation of the human p53 tumor suppressor gene by cMyc/Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol. 14, 7805-7815.
26. Schärer, E., and Iggo, R. (1992). Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20, 1539-1545.
27. Seto, E., Usheva, A., Zambetti, G.P., Momand, J., Horikoshi, N., Weimann, R., and Levine, A.J. (1992). Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89, 12028-12032.
28. Tuck, S., and Crawford, L. (1989). Characterization of the human p53 gene promoter. Mol. Cell. Biol. 9, 2163-2172.
29. Vogelstein, B., and Kinzler, K.W. (1992). p53 function and dysfunction. Cell 70, 523-526.
30. Weintraub, H., Hauschka, S., and Tapscott, S.J. (1991). The MCK enhancer contains a p53 reponsive element. Proc. Natl. Acad. Sci. USA 88, 4570-4571.
31. Wu, H., and Lozano, G. (1994). NF-κB activation of p53. J. Biol. Chem. 269, 20067-20074.